Credit Suisse Ag Genetron Holdings LTD Transaction History

Credit Suisse Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.28 - $2.4 $51,088 - $95,791	-39,913 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.19 - $6.09 $10 - $30	5 Added 0.01%	39,913 $87,000
Q4 2021 Feb 14, 2022	BUY	$5.81 - $14.39 $146,609 - $363,117	25,234 Added 171.96%	39,908 $243,000
Q3 2021 Nov 12, 2021	BUY	$11.55 - $20.3 $26,172 - $45,999	2,266 Added 18.26%	14,674 $203,000
Q2 2021 Aug 16, 2021	BUY	$17.9 - $23.29 $222,103 - $288,982	12,408 New	12,408 $250,000
Q3 2020 Nov 13, 2020	SELL	$9.1 - $15.81 $359,850 - $625,190	-39,544 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$11.29 - $16.0 $446,451 - $632,704	39,544 New	39,544 $477,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.